ASH 2025 | Updated Data for Ascentage Pharmas Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
76.7% complete cytogenetic response rate achieved in patients who failed second-generation TKI…
PDF Solutions to Make Its Analyst Day Webcast and Presentation Available
Company Also Reaffirms 2025 Financial Outlook December 01, 2025 19:01 ET |…
Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference
Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference…
Netrack Showcases Innovative iRack Solutions at BICSI India Technology Seminar in Bengaluru
Netrack, a leader and a renowned name in innovation and manufacturing of…
Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference
October 24, 2025 07:00 ET | Source: Sagimet Biosciences Inc. Denifanstat met…
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc.…
The Shaw Prize Award Presentation Ceremony 2025: Continuing 22 Years of Legacy in Science and Innovation
HONG KONG, Oct. 21, 2025 /PRNewswire/ -- The Shaw Prize presented its…
Netrack Engages Industry Leaders at BICSI Chennai with Future-oriented IT-solutions
Netrack’s participation in the BICSI event in Chennai on December 21st 2024,…
Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platforms Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers…
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety…